Epilepsy is a neurological disorder characterized by recurrent seizures. It affects millions of people worldwide and can have a significant impact on their quality of life. In recent years, medical cannabis has gained attention as a potential treatment option for epilepsy, particularly in cases where conventional therapies have been ineffective. Numerous studies published after 2020 have demonstrated the anticonvulsant properties of cannabinoids found in medical marijuana. 

One study published in 2021 [1] investigated the effectiveness of cannabidiol (CBD), a non-psychoactive compound found in cannabis, in reducing seizure frequency and improving overall seizure control in patients with treatment-resistant epilepsy. The results showed a significant reduction in seizures and improved quality of life. 

Another study from 2022 [2] explored the potential of CBD as an adjunct therapy for pediatric epilepsy and found promising results in terms of seizure reduction. These studies, along with others, suggest that medicinal cannabis, particularly CBD, may offer a valuable alternative for patients with epilepsy. However, it is essential to consult with a healthcare professional and consider individual circumstances before initiating any treatment.

If you or someone you know is interested in starting the medical cannabis certification process, consult with your physician.